T. Rowe Price Associates
ETON icon

T. Rowe Price Associates’s Eton Pharmaceutcials ETON Stock Holding History

T. Rowe Price Associates’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$436K Buy
17,652
+2,283
+15% +$39.9K ﹤0.01% 2518
2025
Q4 		$260K Buy
15,369
+1,845
+14% +$32.5K ﹤0.01% 2714
2025
Q3 		$294K Buy
13,524
+684
+5% +$11.4K ﹤0.01% 2612
2025
Q2 		$183K Buy
+12,840
New +$203K ﹤0.01% 2744
2021
Q4 		– Sell
-24,206
Closed -$122K – 3002
2021
Q3 		$122K Sell
24,206
-193,576
-89% -$1.01M ﹤0.01% 2810
2021
Q2 		$1.34M Buy
+217,782
New +$1.61M ﹤0.01% 1928

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

T. Rowe Price Associates's ETON Position: Q1 2026 in Review

T. Rowe Price Associates increased its Eton Pharmaceutcials (ETON) stake by 15% in Q1 2026, buying an estimated $39.9K and bringing the position to 17,652 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #2518.

T. Rowe Price Associates first reported a position in ETON in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.34M in Q2 2021. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • T. Rowe Price Associates held 17,652 shares of Eton Pharmaceutcials worth $436K as of Q1 2026.
  • T. Rowe Price Associates bought 2,283 Eton Pharmaceutcials shares in Q1 2026, an estimated $39.9K.
  • Eton Pharmaceutcials made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2518 holding.
  • T. Rowe Price Associates first reported a position in Eton Pharmaceutcials in Q2 2021 and has held it in 6 quarters since.
  • T. Rowe Price Associates's Eton Pharmaceutcials position peaked at $1.34M in Q2 2021.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.